查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589208

重症加護診斷市場：通過測試、最終用戶 - 2025-2030 年全球預測

Critical Care Diagnostics Market by Test (Coagulation Testing, Flow Cytometry, Hematology), End-User (Emergency Rooms, Intensive Care Units, Operation Rooms) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年重症加護診斷市場價值為12.3億美元，預計到2024年將達到14.5億美元，複合年成長率為17.97%，預計到2030年將達到39.1億美元。

重症加護診斷涉及使用技術工具和設備來診斷危及生命的病症並監測重症加護室（例如 ICU 和急診科）的治療情況。該領域包括廣泛的測試和設備，包括血液分析儀、診斷影像和分子診斷設備，這對於快速決策和有效管理嚴重和傷害至關重要。慢性和急性疾病的盛行率不斷上升，加上世界人口的老化，增加了對快速、準確的診斷解決方案的需求，證明了對重症加護診斷的需求。其應用範圍從膿毒症和肺炎的早期檢測到監測重要器官功能。最終用戶主要包括醫院、診所和診斷中心，他們不斷需要高效、可靠的診斷選項。

主要市場統計
基準年[2023] 12.3億美元
預測年份 [2024] 14.5億美元
預測年份 [2030] 39.1億美元
複合年成長率（%） 17.97%

影響該市場的關鍵成長要素包括診斷工具的技術進步、醫療保健成本的上升、對以患者為中心的護理的日益關注，以及用於自動化診斷和個人化治療策略的人工智慧和機器學習的整合機會。由於醫療基礎設施的改善和醫療服務投資的增加，新興國家提供了潛在的成長機會。然而，先進診斷設備的高成本、熟練勞動力的缺乏以及嚴格的法律規範等挑戰可能會阻礙市場成長。不同診斷設備之間的互通性問題也產生了限制，需要標準化工作。

需要開拓的創新領域包括開發可攜式和照護現場診斷設備，以顯著減輕醫療機構的負擔並提高可及性。對非侵入性診斷技術和遠端醫療整合等數位健康解決方案的探索預計將提高市場滲透率。市場競爭激烈，技術變革迅速，創新不斷。追求卓越的公司應專注於建立策略夥伴關係、投資研發並擴大產品系列，以滿足重症加護診斷不斷變化的需求。

市場動態：快速發展的重症加護診斷市場的關鍵市場洞察

供應和需求的動態交互作用正在改變重症加護診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界老年人口增加和慢性病盛行率
    • 快速診斷和治療的需求不斷成長
    • 資料管理和電子健康記錄(EHR) 連接性的成長
  • 市場限制因素
    • 診斷工具高成本
  • 市場機會
    • 重症加護診斷的政府活動和引進支持
    • 增加診斷設備和實驗室之間的遠端通訊
  • 市場挑戰
    • 缺乏熟練的專業人員

波特五力：駕馭重症加護診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解重症加護診斷市場的外部影響

外部宏觀環境因素在塑造重症加護診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解重症加護診斷市場的競爭格局

對重症加護診斷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV重症加護診斷市場定位矩陣供應商績效評估

FPNV定位矩陣是評估重症加護診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了重症加護診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對重症加護診斷市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地老年人口不斷增加和慢性病盛行率
      • 對快速診斷和治療的需求不斷增加
      • 改善資料管理和與電子健康記錄 (EHR) 的連接
    • 抑制因素
      • 診斷工具高成本
    • 機會
      • 重症加護診斷的政府活動和實施支持
      • 增加診斷和實驗室之間的遠端通訊
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章重症加護診斷市場測試

  • 血液凝固檢驗
  • 流式細胞技術
  • 血液學
  • 免疫蛋白
  • 微生物與感染疾病
  • 日用化學和特殊化學

第7章重症加護診斷市場：依最終使用者分類

  • 急診室
  • 加護病房
  • 手術室

第8章美洲重症加護診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太重症加護診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的重症加護診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Bayer Healthcare AG
  • Becton, Dickinson & Company
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • HORIBA, Ltd.
  • Johnson and Johnson Service, Inc.
  • Medcaptain Medical Technology Co., Ltd
  • Medtronic PLC
  • Omron Corporation
  • Roche Diagnostics Ltd.
  • Sysmex Corporation
  • WerfenLife, SA
Product Code: MRR-807A20B5CC5E

The Critical Care Diagnostics Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.45 billion in 2024, and is projected to grow at a CAGR of 17.97%, to USD 3.91 billion by 2030.

Critical care diagnostics involves the use of technological tools and equipment to diagnose life-threatening conditions and monitor treatment in critical care settings, such as ICUs and emergency departments. This field encompasses a wide range of tests and devices, including blood analyzers, imaging equipment, and molecular diagnostics, which are essential for swift decision-making and effective management of severe illnesses or injuries. The necessity of critical care diagnostics is underscored by the increasing prevalence of chronic and acute medical conditions, coupled with the aging global population, which heightens the demand for rapid and accurate diagnostic solutions. Their application spans from early detection of sepsis and pneumonia to monitoring vital organ functions, thereby enhancing patient care and outcomes. End users primarily include hospitals, clinics, and diagnostic centers, which continually seek efficient and reliable diagnostic options.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.45 billion
Forecast Year [2030] USD 3.91 billion
CAGR (%) 17.97%

Key growth factors influencing this market include technological advancements in diagnostic tools, increasing healthcare expenditure, and a heightened focus on patient-centric care, highlighting opportunities in the integration of artificial intelligence and machine learning for automated diagnostics and personalized treatment strategies. Emerging economies present potential growth opportunities due to improving healthcare infrastructure and increased investments in healthcare services. However, challenges like high costs of advanced diagnostic devices, a lack of skilled personnel, and stringent regulatory frameworks can impede market growth. Limitations also arise from interoperability issues of different diagnostic devices, necessitating standardization efforts.

Innovation areas ripe for exploration include the development of portable and point-of-care diagnostic devices, which can significantly alleviate burdens on healthcare facilities and improve accessibility. Research into non-invasive diagnostic techniques and digital health solutions, such as telemedicine integration, holds promise for enhanced market penetration. The market is competitive, characterized by rapid technological changes and continuous innovation. Companies looking to excel should focus on forming strategic partnerships, investing in R&D, and expanding their product portfolios to cater to the evolving needs of critical care diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Critical Care Diagnostics Market

The Critical Care Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population worldwide and prevalence of chronic diseases
    • Increasing demand for rapid diagnosis and treatment
    • Growth in data management and connectivity to Electronic Health Record (EHR)
  • Market Restraints
    • High cost of diagnostics tools
  • Market Opportunities
    • Government activities and support for implementing critical care diagnostics
    • Rising remote communications between diagnostics and laboratories
  • Market Challenges
    • Lack of Skilled Professionals

Porter's Five Forces: A Strategic Tool for Navigating the Critical Care Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Critical Care Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Critical Care Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Critical Care Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Critical Care Diagnostics Market

A detailed market share analysis in the Critical Care Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Critical Care Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Critical Care Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Critical Care Diagnostics Market

A strategic analysis of the Critical Care Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Critical Care Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bayer Healthcare AG, Becton, Dickinson & Company, Danaher Corporation, EKF Diagnostics Holdings PLC, F. Hoffmann-La Roche AG, General Electric Company, HORIBA, Ltd., Johnson and Johnson Service, Inc., Medcaptain Medical Technology Co., Ltd, Medtronic PLC, Omron Corporation, Roche Diagnostics Ltd., Sysmex Corporation, and WerfenLife, S.A..

Market Segmentation & Coverage

This research report categorizes the Critical Care Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Coagulation Testing, Flow Cytometry, Hematology, Immunoproteins, Microbial & Infectious Diseases, and Routine & Special Chemistry.
  • Based on End-User, market is studied across Emergency Rooms, Intensive Care Units, and Operation Rooms.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population worldwide and prevalence of chronic diseases
      • 5.1.1.2. Increasing demand for rapid diagnosis and treatment
      • 5.1.1.3. Growth in data management and connectivity to Electronic Health Record (EHR)
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diagnostics tools
    • 5.1.3. Opportunities
      • 5.1.3.1. Government activities and support for implementing critical care diagnostics
      • 5.1.3.2. Rising remote communications between diagnostics and laboratories
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Skilled Professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Critical Care Diagnostics Market, by Test

  • 6.1. Introduction
  • 6.2. Coagulation Testing
  • 6.3. Flow Cytometry
  • 6.4. Hematology
  • 6.5. Immunoproteins
  • 6.6. Microbial & Infectious Diseases
  • 6.7. Routine & Special Chemistry

7. Critical Care Diagnostics Market, by End-User

  • 7.1. Introduction
  • 7.2. Emergency Rooms
  • 7.3. Intensive Care Units
  • 7.4. Operation Rooms

8. Americas Critical Care Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Critical Care Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Critical Care Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bayer Healthcare AG
  • 3. Becton, Dickinson & Company
  • 4. Danaher Corporation
  • 5. EKF Diagnostics Holdings PLC
  • 6. F. Hoffmann-La Roche AG
  • 7. General Electric Company
  • 8. HORIBA, Ltd.
  • 9. Johnson and Johnson Service, Inc.
  • 10. Medcaptain Medical Technology Co., Ltd
  • 11. Medtronic PLC
  • 12. Omron Corporation
  • 13. Roche Diagnostics Ltd.
  • 14. Sysmex Corporation
  • 15. WerfenLife, S.A.

LIST OF FIGURES

  • FIGURE 1. CRITICAL CARE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CRITICAL CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CRITICAL CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRITICAL CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRITICAL CARE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOPROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY MICROBIAL & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY ROUTINE & SPECIAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY EMERGENCY ROOMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY OPERATION ROOMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CRITICAL CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. CRITICAL CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023